Prostate cancer associated transcript 5 (PCAT5)

Prostate cancer associated transcript 5 (PCAT5) is a long non-coding RNA (lncRNA) also known as long intergenic non-protein coding RNA 1452 (LINC01452) and TPCAT-10-36067. PCAT5 is located on chromosome 10p11.21 (10:35778302-35800920) and is highly expressed in ERG-positive castration-resistant prostate cancers. Research indicates that PCAT5 promotes cellular proliferation, invasion, and resistance to apoptosis in prostate cancer cells but does not encode any protein product. As an lncRNA, its principal functional role is to regulate gene expression and chromatin state, contributing to the malignant progression and potential aggressiveness in prostate cancer[1][3][5][7]. **Key notes:** - PCAT5 is not a typical therapeutic target like a receptor, enzyme, or transporter, but its expression may be useful as a diagnostic or prognostic biomarker in prostate cancer and potentially as a future drug target[5]. - There are no known drugs or direct mechanisms of drug action for PCAT5 at this time. - No significant safety concerns are associated with the molecule itself, though targeting lncRNAs may have technical and specificity challenges.

Other names

TPCAT-10-36067LINC01452long intergenic non-protein coding RNA 1452prostate cancer associated transcript 5 (non-protein coding)